[1]
|
Wang, H., Chai, K., Du, M., et al. (2021) Prevalence and Incidence of Heart Failure among Urban Patients in China: A National Population-Based Analysis. Circulation: Heart Failure, 14, e8406.
https://doi.org/10.1161/CIRCHEARTFAILURE.121.008406
|
[2]
|
Bozkurt, B., Coats, A.J.S., Tsutsui, H., et al. (2021) Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. European Journal of Heart Fail-ure, 23, 352-380. https://doi.org/10.1002/ejhf.2115
|
[3]
|
Sonam, D., Lessnick, S.L., Hahn, W.C., et al. (2003) Identification of Genotype-Selective Antitumor Agents Using Synthetic Lethal Chemical Screening in Engineered Human Tumor Cells. Cancer Cell, 3, 285-296.
https://doi.org/10.1016/S1535-6108(03)00050-3
|
[4]
|
Liu, Y., Zeng, L., Yang, Y., et al. (2020) Acyl-CoA Thi-oesterase 1 Prevents Cardiomyocytes from Doxorubicin-Induced Ferroptosis via Shaping the Lipid Composition. Cell Death & Disease, 11, Article No. 756.
https://doi.org/10.1038/s41419-020-02948-2
|
[5]
|
Kim, S.E., Zhang, L., Ma, K., et al. (2016) Ultrasmall Nanoparti-cles Induce Ferroptosis in Nutrient-Deprived Cancer Cells and Suppress Tumour Growth. Nature Nanotechnology, 11, 977-985. https://doi.org/10.1038/nnano.2016.164
|
[6]
|
Ishii, T., Warabi, E. and Mann, G.E. (2019) Circadian Con-trol of BDNF-Mediated Nrf2 Activation in Astrocytes Protects Dopaminergic Neurons from Ferroptosis. Free Radical Biology and Medicine, 133, 169-178.
https://doi.org/10.1016/j.freeradbiomed.2018.09.002
|
[7]
|
Chen, X., Xu, S., Zhao, C., et al. (2019) Role of TLR4/NADPH Oxidase 4 Pathway in Promoting Cell Death through Autophagy and Ferroptosis during Heart Failure. Biochemical and Biophysical Research Communications, 516, 37-43.
https://doi.org/10.1016/j.bbrc.2019.06.015
|
[8]
|
Huang, F., Yang, R., Xiao, Z., et al. (2021) Targeting Ferroptosis to Treat Cardiovascular Diseases: A New Continent to Be Explored. Frontiers in Cell and Developmental Biology, 9, Ar-ticle 737971.
https://doi.org/10.3389/fcell.2021.737971
|
[9]
|
Hu, H., Chen, Y., Jing, L., et al. (2021) The Link between Ferrop-tosis and Cardiovascular Diseases: A Novel Target for Treatment. Frontiers in Cardiovascular Medicine, 8, Article 710963. https://doi.org/10.3389/fcvm.2021.710963
|
[10]
|
Yan, N. and Zhang, J. (2020) Iron Metabolism, Ferropto-sis, and the Links with Alzheimer’s Disease. Frontiers in Neuroscience, 13, Article 1443. https://doi.org/10.3389/fnins.2019.01443
|
[11]
|
Fang, X., Cai, Z., Wang, H., et al. (2020) Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis. Circulation Research, 127, 486-501. https://doi.org/10.1161/CIRCRESAHA.120.316509
|
[12]
|
Melenovsky, V., Petrak, J., Mracek, T., et al. (2017) Myocardial Iron Content and Mitochondrial Function in Human Heart Failure: A Direct Tissue Analysis. European Journal of Heart Failure, 19, 522-530.
https://doi.org/10.1002/ejhf.640
|
[13]
|
Lin, X., Ping, J., Wen, Y., et al. (2020) The Mechanism of Ferroptosis and Applications in Tumor Treatment. Frontiers in Pharmacology, 11, Article 1061. https://doi.org/10.3389/fphar.2020.01061
|
[14]
|
Jiang, L., Kon, N., Li, T., et al. (2015) Ferroptosis as a p53-Mediated Activity during Tumour Suppression. Nature, 520, 57-62. https://doi.org/10.1038/nature14344
|
[15]
|
Hayano, M., Yang, W.S., Corn, C.K., et al. (2016) Loss of Cyste-inyl-tRNA Synthetase (CARS) Induces the Transsulfuration Pathway and Inhibits Ferroptosis Induced by Cystine Dep-rivation. Cell Death & Differentiation, 23, 270-278.
https://doi.org/10.1038/cdd.2015.93
|
[16]
|
Liu, M.R., Zhu, W.T. and Pei, D.S. (2021) System Xc−: A Key Regula-tory Target of Ferroptosis in Cancer. Investigational New Drugs, 39, 1123-1131. https://doi.org/10.1007/s10637-021-01070-0
|
[17]
|
Stockwell, B.R. (2022) Ferroptosis Turns 10: Emerging Mecha-nisms, Physiological Functions, and Therapeutic Applications. Cell, 185, 2401-2421. https://doi.org/10.1016/j.cell.2022.06.003
|
[18]
|
Yagoda, N., Rechenberg, M.V., Zaganjor, E., et al. (2007) RAS-RAF-MEK-Dependent Oxidative Cell Death Involving Voltage-Dependent Anion Channels. Nature, 447, 864-868. https://doi.org/10.1038/nature05859
|
[19]
|
Yang, W.S., Kim, K.J., Gaschler, M.M., et al. (2016) Peroxidation of Polyunsaturated Fatty Acids by Lipoxygenases Drives Ferroptosis. Proceedings of the National Academy of Sciences of the United States of America, 113, E4966- E4975. https://doi.org/10.1073/pnas.1603244113
|
[20]
|
Stockwell, B.R., Friedmann Angeli, J.P., Bayir, H., et al. (2017) Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell, 171, 273-285. https://doi.org/10.1016/j.cell.2017.09.021
|
[21]
|
Bolinder, J., Ljunggren, O., Johansson, L., et al. (2014) Dapagliflozin Maintains Glycaemic Control While Reducing Weight and Body Fat Mass over 2 Years in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin. Diabetes, Obesity and Metabolism, 16, 159-169. https://doi.org/10.1111/dom.12189
|
[22]
|
Docherty, K.F., et al. (2022) Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings from DAPA-HF. Circulation, 146, 980-994. https://doi.org/10.1161/CIRCULATIONAHA.122.060511
|
[23]
|
Huang, B., Wen, W.J. and Ye, S.D. (2022) Dapagliflozin Ameliorates Renal Tubular Ferroptosis in Diabetes via SLC40A1 Stabilization. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 9735555.
https://doi.org/10.1155/2022/9735555
|
[24]
|
Gu, J., et al. (2010) Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi). The Journal of Clinical Pharma-cology, 50, 401-414.
https://doi.org/10.1177/0091270009343932
|
[25]
|
Sacubitril Valsartan Sodium Tablets Description. 2021-05-24.
|
[26]
|
Murphy, S.P., Kakkar, R., McCarthy, C.P. and Januzzi Jr., J.L. (2020) Inflammation in Heart Failure: JACC State-of- the-Art Review. Journal of the American College of Cardiology, 75, 1324-1340.
https://doi.org/10.1016/j.jacc.2020.01.014
|
[27]
|
Follmann, M., Ackerstaff, J., Redlich, G., et al. (2017) Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure. Journal of Medicinal Chemistry, 60, 5146-5161.
https://doi.org/10.1021/acs.jmedchem.7b00449
|
[28]
|
McMurray, J., Adamopoulos, S., Anker, S.D., et al. (2012) ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012: The Task Force for the Di-agnosis and Treatment of Acute and Chronic Heart Failure 2012of the European Society of Cardiology. Developed in Collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal, 33, 1787-1847. https://doi.org/10.1093/eurheartj/ehs104
|
[29]
|
Li, X.Y. and Leung, P.S. (2020) Erastin-Induced Ferroptosis Is a Regulator for the Growth and Function of Human Pancreatic Islet-Like Cell Clusters. Cell Regeneration, 9, Article No. 16. https://doi.org/10.1186/s13619-020-00055-3
|
[30]
|
Zuo, G.F., et al. (2019) Inhibition of JNK and p38 MAPK-Mediated Inflammation and Apoptosis by Ivabradine Improves Cardiac Function in Streptozotocin-Induced Dia-betic Cardiomyopathy. Journal of Cellular Physiology, 234, 1925-1936. https://doi.org/10.1002/jcp.27070
|
[31]
|
Shi, P., et al. (2021) Neutrophil-Like Cell Membrane-Coated siRNA of lncRNA AABR07017145.1 Therapy for Cardiac Hypertrophy via Inhibiting Ferroptosis of CMECs. Molecular Therapy Nucleic Acids, 27, 16-36.
https://doi.org/10.1016/j.omtn.2021.10.024
|
[32]
|
Bai, Y.P., Chen, J.P. and Liu, Z.N. (2021) Ivabradine Inhibits Myocardial Fibrosis and Myocardial Protection by Regulating TIMP-1 Expression in Rats with Coronary Heart Disease. Medical Journal of West China, 33, 1126-1132. (In Chinese)
|